AQUI-S®20E (10% eugenol; AQUI-S New Zealand, Ltd., Lower Hutt, New Zealand) is a candidate for U.S. Food and Drug Administration (FDA) approval for use as an immediate-release sedative in fisheries research, fisheries management, and fish culture. As part of the ongoing AQUI-S®20E approval process, efficacy trials have been conducted on a variety of freshwater-reared finfishes (e.g., Bowker et al. 2013a, 2013b, and 2013c). In addition, we conducted a pilot trial to investigate the influence of fish life stage, water temperature, and eugenol concentration on the times required for freshwater-reared Rainbow Trout Oncorhynchus mykiss to become handleable and recover from handleable when sedated with AQUI-S®20E.
Publication date
Type of document
Fact Sheet
Program
Species